GlassScriptPhysician profile
Vishal Goyal
NPI 1205124898
$5,517.67
in general payments reported to CMS, 2019-2025
29 companies · $552 in 2025
The $552 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2021: $1,215 · 2022: $1,968 · 2023: $565 · 2024: $613 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Education: $24.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.00 |
| Education | $24.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,320.52 | 2021-2025 | Ensite, Aveir, Agilis |
| Biosense Webster, INC. | $904.31 | 2019-2025 | Carto 3, Qdot Micro |
| Boston Scientific Corporation | $883.15 | 2019-2025 | Watchman Flx |
| Medtronic, INC. | $795.40 | 2021-2024 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $340.83 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $246.17 | 2023-2025 | Assure Wcd |
| Medical Device Business Services, INC. | $212.09 | 2019 | |
| Amgen INC. | $131.29 | 2021-2022 | |
| Cardiva Medical, INC. | $92.33 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biotronik INC. | $85.84 | 2023 | Selectra, Solia, Biomonitor |
| Philips North America LLC | $84.28 | 2022 | |
| Atricure, INC. | $52.83 | 2022-2024 | |
| Acumed LLC | $48.44 | 2025 | Acumed, Inframe Implant, Innate Implant |
| Kiniksa Pharmaceuticals International, Plc | $39.74 | 2024 | Arcalyst |
| Chiesi USA, INC. | $28.14 | 2023 | Cleviprex, Kengreal |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $24.43 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $24.29 | 2022 | |
| Impulse Dynamics (USA) INC. | $21.10 | 2022 | |
| Edwards Lifesciences Corporation | $20.38 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alnylam Pharmaceuticals INC. | $19.45 | 2025 | Onpattro |
| Inspire Medical Systems, INC. | $17.78 | 2024 | Inspire |
| Scpharmaceuticals INC. | $17.45 | 2025 | |
| Pfizer INC. | $17.09 | 2022 | |
| Stryker Corporation | $15.54 | 2025 | N/A |
| Ethicon US, LLC | $15.52 | 2023 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
| Merck Sharp & Dohme LLC | $15.24 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Cvrx, INC. | $14.71 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $14.33 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.